Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.410
-0.120 (-4.74%)
Nov 24, 2025, 4:00 PM EST - Market closed
CMMB's stock price has decreased by -63.48% in the past year and price targets may not have had time to catch up.

Chemomab Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$26.50
Upside
+999.59%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
BuyMaintains$10$25+937.34%Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
BuyMaintains$44$40+1,559.75%May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong BuyMaintains$16$28+1,061.83%Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
BuyReiterates$52$44+1,725.73%Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong BuyInitiates$16+563.90%May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
BuyUpgrades$24+895.85%May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
HoldMaintainsn/an/aMar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+1,061.83%Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+1,061.83%Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
BuyMaintains$48$28+1,061.83%Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
BuyMaintains$120$80+3,219.50%Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong BuyInitiates$120+4,879.25%Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
BuyInitiates$180+7,368.88%May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
BuyInitiates$168+6,870.95%May 7, 2021